%PDF-1.6
%
1 0 obj
<<
/Lang (de-DE)
/MarkInfo <<
/Marked true
>>
/Metadata 2 0 R
/OpenAction [3 0 R /FitH -32768]
/Outlines 4 0 R
/PageMode /UseOutlines
/Pages 5 0 R
/StructTreeRoot 6 0 R
/Type /Catalog
/ViewerPreferences <<
/CenterWindow true
>>
>>
endobj
7 0 obj
<<
/Author ()
/CreationDate (D:20210624155904+02'00')
/Creator (Adobe InDesign 14.0 \(Windows\))
/Keywords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
/ModDate (D:20210624160037+02'00')
/Producer (Adobe PDF Library 15.0; modified using iText 2.1.7 by 1T3XT)
/Subject (Fachinformation)
/Title <496E7265626963AE20313030206D6720486172746B617073656C6E>
/Trapped /False
>>
endobj
2 0 obj
<<
/Length 7507
/Subtype /XML
/Type /Metadata
>>
stream
application/pdf
Fachinformation
Rote Liste Service GmbH
Rote Liste
Fachinfo-Service
Arzneimittelverzeichnis
Fachinformation
Fachinfo
Zusammenfassung der Merkmale des Arzneimittels
SPC
Summary of Product Characteristics
SMPC
Fertigarzneimittel
Pharmazie
Gebrauchsanweisung für Fachkreise
Arzneimittel
Medizin
Präparat
Wirkstoffe
Darreichungsformen
Stärke
Indikationen
Anwendungsgebiete
Dosierungen
Wirkung
Nebenwirkungen
Arzneimittelwechselwirkungen
Wechselwirkungen
Kontraindikationen
Gegenanzeigen
Fachkreise
PZN
Zulassung
BfArM
Bundesinstitut für Arzneimittel und Medizinprodukte
EMA
European Medicines Agency
PEI
Inrebic® 100 mg Hartkapseln
2021-06-24T15:59:04+02:00
2021-06-24T16:00:37+02:00
2021-06-24T16:00:37+02:00
Adobe InDesign 14.0 (Windows)
uuid:21c1ec39-afcb-4b5e-a7b6-5fea23ab6112
xmp.did:d5bb255f-d284-e24a-b8f9-4b941bcbbb84
xmp.id:eedb4481-76b6-ca42-a392-a9ce932e70d9
proof:pdf
xmp.iid:bbca8c52-b6af-364d-8082-a08d10018436
xmp.did:ef4ed72d-9013-a24c-be93-ac4342231bfc
xmp.did:d5bb255f-d284-e24a-b8f9-4b941bcbbb84
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 14.0 (Windows)
/
2021-06-24T15:59:04+02:00
Adobe PDF Library 15.0; modified using iText 2.1.7 by 1T3XT
False
Rote Liste Service GmbH; Rote Liste; Fachinfo-Service; Arzneimittelverzeichnis; Fachinformation; Fachinfo; Zusammenfassung der Merkmale des Arzneimittels; SPC; Summary of Product Characteristics; SMPC; Fertigarzneimittel; Pharmazie; Gebrauchsanweisung für Fachkreise; Arzneimittel; Medizin; Präparat; Wirkstoffe; Darreichungsformen; Stärke; Indikationen; Anwendungsgebiete; Dosierungen; Wirkung; Nebenwirkungen; Arzneimittelwechselwirkungen; Wechselwirkungen; Kontraindikationen; Gegenanzeigen; Fachkreise; PZN; Zulassung; BfArM; Bundesinstitut für Arzneimittel und Medizinprodukte; EMA; European Medicines Agency; PEI
endstream
endobj
3 0 obj
<<
/ArtBox [0 0 595.276 841.89]
/BleedBox [0 0 595.276 841.89]
/Contents 8 0 R
/CropBox [0 0 595.22 842]
/MediaBox [0 0 595.22 842]
/Parent 5 0 R
/Resources 9 0 R
/Rotate 0
/TrimBox [0 0 595.276 841.89]
/Type /Page
>>
endobj
4 0 obj
<<
/Count 31
/First 10 0 R
/Last 10 0 R
>>
endobj
5 0 obj
<<
/Count 8
/ITXT (2.1.7)
/Kids [3 0 R 11 0 R 12 0 R 13 0 R 14 0 R 15 0 R 16 0 R 17 0 R]
/Type /Pages
>>
endobj
6 0 obj
<<
/ClassMap 18 0 R
/ParentTree 19 0 R
/ParentTreeNextKey 9
/RoleMap 20 0 R
/Type /StructTreeRoot
>>
endobj
8 0 obj
<<
/Length 8047
/Filter /FlateDecode
>>
stream
x\rƕ%"U, 211nՒEʚQc$"*
嶸Wo
WZ̹@IRvMId{=M/^{}~볣}(R"a{1>`~<㿜%<a:O%8ZO߅:Me& [7ʵtXUUsW"˔4^]}%])-5`#k+2£.OGXHE/g (Dn̔%FƇREKQzٗvoo1ɌxTgx7:>(vV',I(Ŕ`u8EQi:Dsy0a
ycdۖ1Rlʲ`!i"͢TbS4N6"R\+=4wvͬ,zS<'L" cI1MNK,Zd*-ob2QHؚt8}o~W*o +iIILFxxyfvkt
wIjt*u&3#/۲ly]n*i뢺w}dŖ/w|U;>TE.Xk&(QHa.%\(<%1$?ZxT^H<Qkbn/?>oFcFn'caMYzU]lWeYQVˇ lL#D3CX7:c7Bc}Uyu[T쟗 1+KiMЦ @
xDvM@y[+x뢪˛,UNwEUabr: ?.~VnW_8v]-:b'ղ-4*lZScsƦ%^7$MoD570YYW+B>f*`9<1F
)g0: 0OY1gnmW+CgeQ}*wd=[+!^,F!dRW3IbgSQb+EkfLK
3@,nvrI bHQ'Li8ɀBb)R<3ZU)B$34Y:R^tWg?eoN?{sISiM2@%$)8T%ȤHgXR^=7YAY+:_dQp)yH6aP78\ s쇳7]~Т!E!HU ܢO?zv~z٠!dMM 5 (-0f_[d檼\)oY<(ʀr**vٖjC'ywn,.#ӄzy 1J}gufvj`=` ȶ"!1n6ծ~ {O7rWTWU!V5سT&F`Ϋ(W1CBCI H[W1IҬ}
i_!rh9UBRO=4S3M2i#69kJmGRw@zJ^D(%NWJc0b+pUE{`RgY;/O|c4\=7W/B1P|XPkwvYy?U1ˁ~w篿:%mۓWgp"Mcב+J%TQ'yR]
Ґ!̸[Eɐ6t?5qW-@`6O9i+FЧ>
H4
nWw]\߯j.9h; Cr{PmT}!^]%s}WTH
2XKY\?|vsܔ.M퀜mv竟ۼXK.FէokDBÇS?,U
s#~HGpQGZ0xHD
{qA^_nuY&ȍ*W e=iiY/u@ANF\|;Ϋnb}P}ro>ςDM7rɗ'0-/z^ڸ(@PlQbM%e,\ھe*-`>}Sd"(ĠJOpH8{jP2 TT
ǜXAo8kH&}AZ|tfw":;CY^bca &] H}B8ԲXd_}]iT]"V^V8/?۰\{ܖ**,}-cef>FR<7\P8n aPF)Cxnol˲*֖,^+$LgYbT?~fՏۘ3[|cC7hl+bge~..p P$N5=6άH..@hV="O/hZZ?35!Gv%GU'icVߎd"xtC7f hmłڂ|ea'x߁~w+v<(EW(L
bˀY ?l_[]ܖnPWh6Є-ąg"ݥYKcV\]o}^cvyŷ}U5wkRҾ$F[/0Ԛ.oaW?}h 7sjv)`MhkSK""vJhו_XvlJne1[k
Fz&O^ac-7UY1.|0\LnJ$' pHz_@+B栿zQFh4)2 SIRhѪB)rZlDiЩ&\QêAyݧ!Rhݎ(Xо9JkUJF_bwgG"vLەK\E/Be4ߩ'jOw(<
Q^TK!2&A\$%&\!h_,r=9{mlDٌA_?+
DjGg.`Z@'LS=@01.!̖?Xl]2:|twO(3
7OdKJ)iC|bbSk';ssqWS
-\.ϖ%г!.jWwVaZwa_~^B?K]Hݐ"XIq~;
pE݈nY*ayȦ
,A즨kޝqi˷D#Z1,Ѣ}\K6ua˴wdwg:5]a_=o}F+e̽Ujϣm;^Tx-RuGDpH2i\ի(ȳP6V2x7حˢ>.kͦT$X[܉`Xhh:{01qxvW]}#Ϧ$~WS^oؘD@
q`4C G^G2Q4'9jbTUB\na^ݻ)h$b*Ԑ8[Ëu^oV_ '/T+Ģ}R9|KP֏dZ8V@Yz,Qq 56p³qPC{f<ܻrgb>1}:F!,xAMBzzzGdàuj7ÌUI [''Oh2ؔzE>#J0|\-][3g˾ccjCJ"h\Rzةљ1WANj?bitN<+[:0lv߲ƀ~%4)C`_:k#C4)KR!Di_&*{q0"
71Qbxc_?Iax A#hjv^eNߤbZmAH=8hp3{GPƦnBTMCfQ`}u h[Cq6y}[ F-Ljz6P4"jj;m Bn{NdC!Ʉ),@x
tUºf
$ 2EBbnŠ,o 7jA,ӱD2HR_p>
dgmᄙm^
Pm
iyjzzlLt8:щ|(~=Dl%'|*bM^c̳(>ae RtE''AjJ_J~fi]wOGjTa3S Nh,rqÒew&!h"%RB=hK":
/}"\(u_j&1^wD-"?5%1G(v:rSvkTg'r`벸 9pDIؕv%UMm68QRi4{2 &Mj,K#}nrߎK*"6eI9%Nzhޤߛ=Mu"Rڬvg|HEp{J2|PhZm4)No\(خlGE 1.vMwq ОN-PI \ܴqFj7 ;[D5DsJI;Ganq Lv,Iz2`No 5/ F
lR":oND8lKz6sٓ90Q*V]NΤyS&;pxE&)^+!>Bf/-Dt&O01
̂X:< օ]0h0*TMPty(< ΨغboAv[4*TLuO8_5+w|m\7@Rk^3՞ZQP[z*P'TsK|[9qZݷwEl#/Xu7x.Ga[cй;0jE컽`,@,
:6wz3En97=91*$Նk~TdbC}Y\:9Lo*.`H+iYL8P~@=7qy~Ii7r*R Yc%tH-qWae{,w~Zz Mār{4HEC6umpW3hg.0or9 Mk~,psdzhuh#'Bo7 TH:TJu0ŲmNLH-_$AJ4 &|ާc{?*ʊ4MͫMu'Rsy75G3n."{a'
^[eg#1}zl>4*bO
MA,"bT֧J*iTn2mipG 8/3a]/;Y'}GJOaȌbX|[j9V&GɊZ4RI}8Dӆ8W `ldGLںrjtW,ڈBaTlKf/l~z[G(Ihwܺ'?crxӵjɡn^n^=Nl]+6@TLB*`=
ܫAC2]